Stem cell therapy has emerged as a groundbreaking treatment option for corneal injuries, offering hope to individuals ...

In this article, we will be taking a look at the 15 best biotech stocks to buy according to billionaires. Although biotech ...

Q4 2024 Earnings Call Transcript March 13, 2025 Allogene Therapeutics, Inc. beats earnings expectations. Reported EPS is ...

My survival is based on research. With limited NIH funding, I fear that my life, and the lives of others, will be left ...

As part of the National Resident Matching Program, fourth-year medical students at Mayo Clinic Alix School of Medicine and ...

A first of its kind surgery to help people with a specific type of heart failure is going through clinical trials at Providence St. Vincent’s.

The ESMO Sarcoma and Rare Cancers Congress 2025, to be held from 20-22 March in Lugano, Switzerland, will be the convergence point for world-renowned experts to present and discuss developments in the ...

Thursday's session focused on the "Future of Medicine" program through Care Access. This health screening initiative provides ...

Jaguar expects first results in Q2 2025 of proof-of-concept investigator-initiated trials of crofelemer for the rare diseases short bowel syndrome with intestinal failure and microvillus inclusion dis ...

Noon, is tackling ALS and other neurological disorders with a bold, multi-targeted approach. Fueled by a personal encounter with an ALS advocate, Ben-Noon assembled a team of top scientists to develop ...

This unexpected early warning sign relates to a change in sensory perception, specifically your sense of smell. A declining ...

Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) (”Aspire” or the “Company”), a developer of a multi-faceted patent-pending drug delivery technology, today provided an update on its two patent ...